1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Summary of population and results
Summary
Age (median) (IQR) (yr)64 (57–76)
Male (No.) (%)38 (68%)
Hypertension (No.) (%)41 (71%)
Diabetes (No.) (%)17 (29%)
Dyslipidemia (No.) (%)41 (71%)
Current aspirin use (No.) (%)22 (38%)
Current clopidogrel use (No.) (%)6 (10%)
Current/former smoker (No.) (%)22 (38%)/14 (24%)
Baseline NIHSS (median) (IQR)15 (11–20)
Baseline ASPECTS 8–10/5–7 (No.) (%)47 (81%)/11 (19%)
Carotid Terminus occlusion (No.) (%)25 (43%)
M1 occlusion (No.) (%)22 (38%)
M2 occlusion, (No.) (%)11 (19%)
tPA administration (No.) (%)25 (43%)
Acute angioplasty alone (No.) (%)20 (34%)
Acute angioplasty and stent placement (No.) (%)38 (66%)
Delayed stent or endarterectomy within a week (No.) (%)6 (10%)
mTICI score > 2a (No.) (%)56 (96%)
Acute carotid artery re-occlusion (No.) (%)4 (7%)
Any ICH (No.) (%)18 (31%)
Symptomatic ICH (No.) (%)1 (2%)
30- to 60-Day carotid patency (No.) (%)42/49 (86%)
90-Day mRS 0–2 (No.) (%)42 (72%)
  • Note:—IQR indicates interquartile range; ICH, intracranial hemorrhage.